Distinct glycolysis inhibitors determine retinal cell sensitivity to glutamate-mediated injury

Neurochemical Research

Volumn 24, Issue 3, 1999, Pages 351-358

  Rego, Ana Cristina ^a   Areias, Filipe M ^a   Santos, Maria Sancha ^a   De Oliveira, Catarina Isabel Resende ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

ATP production; Glutamate; Glycolysis; MTT reduction; Retinal cell injury

Indexed keywords

ANIMAL CELL; ARTICLE; CHICKEN; ENERGY CONSUMPTION; GLYCOLYSIS; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RETINA CELL; RETINA INJURY;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELLS, CULTURED; CHICK EMBRYO; COLORING AGENTS; DEOXYGLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GLUCOSE; GLUTAMIC ACID; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; GLYCOLYSIS; IODOACETIC ACID; KINETICS; OXIDATION-REDUCTION; RETINA; TETRAZOLIUM SALTS; THIAZOLES;

ANIMALIA; GALLUS GALLUS;

EID: 0032964352     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020977331372     Document Type: Article

References (35)

1. Cunha-Vaz, J. G., Leite, E., Castro Sousa, J.P., and Faria de Abreu, J. R. 1993. Blood-retinal barrier permeability and its relation to progression of diabetic retinopathy. A four year follow-up study. Graefe's Arch. Clin. Exp. Ophthalmol. 231:141-145.
2. Weiss, H. 1972. The carbohydrate reserve in the vitreous body and retina of the rabbit's eye during and after pressure ischaemia and insulin hypoglycaemia. Ophthalmol. Res. 1:360-371.
3. + uptake require glycolysis. Federation Proc. 42:2875-2880.
4. Kauppinen, R. A., and Nicholls, D. G. 1986. Failure to maintain glycolysis in anoxic nerve terminals. J. Neurochem. 47:1864-1869.
5. Longuemare, M. C., Hill, M. P., and Swanson, R. A. 1994. Glycolysis can prevent nonsynaptic excitatory amino acid release during hypoxia. NeuroReport 5:1789-1792.
6. Zeevalk, G. D., and Nicklas, W. J. 1990. Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J. Pharmacol. Exp. Therap. 253:1285-1292.
7. Rego, A. C., Santos, M. S., and Oliveira, C. R. 1997. Adenosine triphosphate degradation products upon oxidative stress and metabolic dysfunction situations. J. Neurochem. 69:1228-1235.
8. Rego, A. C., Santos, M. S., and Oliveira, C. R. 1996. Oxidative stress, hypoxia, and ischemia-like conditions increase the release of endogenous amino acids by distinct mechanisms in cultured retinal cells. J. Neurochem. 66:2506-2516.
9. Obrenovitch, T. P., and Urenjak, J. 1997. Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog. Neurobiol. 51:39-87.
10. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:55-63.
11. Slater, T. F., Sawyer, B., and Sträuli, U. 1963. Studies on succinate-tetrazolium reductase system. III. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta 77:383-393.
12. Keller, J. N., Mark, R. J., Bruce, A. J., Blanc, E., Rothstein, J. D., Uchida, K., Waeg, G., and Mattson, M. P. 1997. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80:685-696.
13. Keller, J. N., Pang, Z., Geddes, J. W., Begley, J. G., Germeyer, A., Waeg, G., and Mattson, M. P. 1997. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:273-284.
14. Musser, D. A., and Oseroff, A. R. 1994. The use of tetrazolium salts to determine sites of damage to the mitochondrial electron transport chain in intact cells following in vitro photodynamic therapy with photofrin II. Photochem. Photobiol. 59:621-626.
15. 3H]GABA in cultured chick retinal cells. Brain Res. 655:213-221.
16. Huba, R., and Hofmann, H. D. 1990. Identification of GABAergic amacrine cell-like neurons developing in retina monolayer cultures. Neurosci. Lett. 117:37-42.
17. 2-induced oxidative stress. J. Neurochem. 67:1153-1163.
18. Sedmak, J. J., and Grossberg, S. E. 1977. A rapid sensitive and versatile assay for protein using Coomassie Brilliant Blue G250. Anal. Biochem. 79:544-552.
19. Stocchi, V., Cucchiarini, L., Chiarantini, L., Palma, P., and Crescentini, G. 1985. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells. Anal. Biochem. 146:118-124.
20. Kaneko, I., Yamada, N., Sakuraba, Y., Kamenosono, M., and Tutumi, S. 1995. Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue. J. Neurochem. 65:2585-2593.
21. Shearman, M. S., Hawtin, S. R., and Tailor, V. J. 1995. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides. J. Neurochem. 65:218-227.
22. Dhanjal, P., and Fry, J. R. 1997. Determinants of MTT reduction in rat hepatocytes. Biomarkers 2:111-116.
23. Patel, A. J., Gunasekera, S., Jen, A., and de Silva, H. A. R. 1996. β-Amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration. NeuroReport 7: 2026-2030.
24. Liu, Y., Peterson, D. A., Kimura, H., and Schubert, D. 1997. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69:581-593.
25. Burdon, R. H., Gill, V., and Rice-Evens, C. 1993. Reduction of a tetrazolium salt and superoxide generation in human tumor cells (HeLa). Free Rad. Res. Commun. 18:369-380.
26. Altman, F. P. 1976. Tetrazolium salts and formazans. Prog. Histochem. Cytochem. 9:1-56.
27. 3H]dopamine in rat striatal slices. Neurochem. Int. 28:501-507.
28. Cheng, B., McMahon, D. G., and Mattson, M. P. 1993. Modulation of calcium current, intracellular calcium levels and cell survival by glucose deprivation and growth factors in hippocampal neurons. Brain Res. 607:275-285.
29. i in pulmonary arterial smooth muscle cells. Am. J. Physiol. 269:L203-L208.
30. Romano, C., Price, M. T., and Olney, J. W. 1995. Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina. J. Neurochem. 65:59-67.
31. Gemba, T., Oshima, T., and Ninomiya, M. 1994. Glutamate efflux via the reversal of the sodium-dependent glutamate transporter caused by glycolytic inhibition in rat cultured astrocytes. Neuroscience 63:789-795.
32. Okazaki, S., Nishida, Y., Kawai, H., and Saito, S. 1996. Acute neurotoxicity of L-glutamate induced by impairment of the glutamate uptake system. Neurochem. Res. 21:1201-1207.
33. Velasco, I., Tapia, R., and Massieu, L. 1996. Inhibition of glutamate uptake induces progressive accumulation of extracellular glutamate and neuronal damage in rat cortical cultures. J. Neurosci. Res. 44:551-561.
34. Williams, R. J., Murphy, N., Glowinski, J., and Prémont, J. 1995. Glucose regulates glutamate-evoked arachidonic acid release from cultured striatal neurons. J. Neurochem. 65:241-249.
35. Williams, R. J., Maus, M., Stella, N., Glowinski, J., and Prémont, J. 1996. Reduced glucose metabolism enhances the glutamate-evoked release of arachidonic acid from striatal neurons. Neuroscience 74:461-468.